- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01727557
Anesthetic Technique for AV Fistulae Creation
March 1, 2018 updated by: Naum Shaparin, Montefiore Medical Center
This study is being done to compare the two anesthesia techniques which are commonly used in the formation of arteriovenous fistulas: local anesthesia and regional anesthesia.
Local anesthesia means that, your doctor will inject numbing medication directly into the tissue or part of your body where the surgery will be done.
In this case, the numbing medication will be injected directly into the area where your fistula will be made.
In regional anesthesia, the numbing medication will be injected around the nerve (part of the body that gives sensation) for your arm, to make the entire arm numb.
The purpose of this study is to compare the three month success rates of AV fistulae created by the two anesthesia techniques.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The primary objectives of the study are:
- To evaluate the three-month success rate for AV fistulas constructed while using regional anesthesia against those constructed while using local anesthesia. Success will be evaluated by a dialysis access ultrasound, which will be performed three months after completion of the procedure. Successful will be defined as a mean blood flow of 600 ml/min and above, or receiving hemodialysis using the newly created AV fistula.
- To evaluate the immediate (within 3 days) and long-term complications three months after AV fistula construction under regional anesthesia or local anesthesia.
The secondary objective of the study is to use a short questionnaire survey To assess patient comfort level after creation of AV fistula (e.g. nausea, analgesia).
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 21-70 years old
- Able to give informed consent
- Creation of first time AV fistula
- Possible 3 month follow up visit
- ASA-I-IV
Exclusion Criteria:
- BMI ≥40
- Repeated AV fistula creation,
- ASA -V,
- Allergic to local anesthetic agents,
- Significant lung and cardiac disease,
- Infection at the site of regional anesthesia,
- Pre-existing peripheral nerve damage,
- Significant bleeding disorders,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Local anesthesia
|
Regional anesthesia will be compared to local anesthesia
|
Active Comparator: regional anesthesia
|
Regional anesthesia will be compared to local anesthesia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AV fistula success rate
Time Frame: Three months from the day of creation
|
To evaluate the three-month success rate for AV fistulas constructed while using regional anesthesia against those constructed while using local anesthesia.
Success will be evaluated by a dialysis access ultrasound, which will be performed three months after completion of the procedure.
Successful will be defined as a mean blood flow of 600 ml/min and above, or receiving hemodialysis using the newly created AV fistula.
|
Three months from the day of creation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short term comfort level
Time Frame: Within three days of procedure
|
To assess patient comfort level after creation of AV fistula (e.g.
nausea, analgesia).
|
Within three days of procedure
|
Short term safety, number of post operative complications
Time Frame: Three days after the creation
|
b) To evaluate the immediate complications (within 3 days)after AV fistula construction under regional anesthesia or local anesthesia.
|
Three days after the creation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
July 15, 2016
Study Completion (Actual)
July 15, 2016
Study Registration Dates
First Submitted
June 8, 2012
First Submitted That Met QC Criteria
November 15, 2012
First Posted (Estimate)
November 16, 2012
Study Record Updates
Last Update Posted (Actual)
March 5, 2018
Last Update Submitted That Met QC Criteria
March 1, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-08-302
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Failure on Dialysis
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
-
The University of Hong KongBaxter Healthcare CorporationCompleted
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd Stage Renal Failure on DialysisUnited States
-
Massachusetts General HospitalCompletedEnd Stage Renal Failure on DialysisUnited States
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedEnd Stage Renal Failure on Dialysis
-
Palo Alto Veterans Institute for ResearchUnknownEnd Stage Renal Failure on DialysisUnited States
-
Praxisverbund Dialyse und AphereseCompletedEnd Stage Renal Failure on Dialysis
-
Hallym University Medical CenterWithdrawnEnd Stage Renal Failure on DialysisKorea, Republic of
-
Oxford Brookes UniversityOxford University Hospitals NHS TrustCompletedEnd Stage Renal Failure on DialysisUnited Kingdom
-
Merit Medical Systems, Inc.CryoLife, Inc.WithdrawnEnd Stage Renal Failure on DialysisUnited States
Clinical Trials on regional anesthesia
-
IRCCS Policlinico S. MatteoCompleted
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteActive, not recruitingHip FracturesUnited States, Canada
-
Aretaieion University HospitalCompleted
-
Fayoum University HospitalCompletedPost Operative PainEgypt
-
Ondokuz Mayıs UniversityCompletedChronic Pain | Analgesia | Acute PainTurkey
-
American Hospital of ParisNataliya KARASHCHUK; Briana LUI; Thierry GUENOUN; Stephane ROMANORecruitingPain | Regional Anesthesia | Intraoperative MonitoringFrance
-
Hospital de Clinicas de Porto AlegreActive, not recruitingPeripheral Vascular DiseasesBrazil
-
University Hospital Hradec KraloveCompletedAnesthesia | Glycocalyx | Perfused Boundary Region
-
Karolinska InstitutetCompletedPostoperative Pain | Distal Radius FractureSweden